Making protein quantification simple

Our mission at Abselion is to simplify protein quantification for the scientists making crucial decisions to accelerate the development of biotherapeutics. Our novel analytical instrumentation and sensor technology helps researchers to develop the medicine of the future and to find the best ways to produce new biomolecules.

Amperia Demo
Amperia Demo

We focus on convenient, fast yet flexible, analytical tools with high degree of automation and accuracy to accelerate access to actionable data at the point of need.

Our award-winning Amperia system, built on proprietary Redox Electrochemical Detection (RED) technology, brings a new approach to biologics and viral-vector quantification for confident, convenient and cost-effective at-line titre measurement at any bench or bioreactor. By enabling agile and straightforward access to data, scientists are empowered to make immediate decisions that can drive bioprocess optimisation and innovation.

Based in Cambridge, UK, we are a dynamic, interdisciplinary team working at the intersection of biology, nanotechnology and data science. We value a flat hierarchy, where everyone is encouraged to share their ideas and to follow their passion.

{

The best technologies in the world are of little use, if they are not affordable and simple to use. With RED, we have the technology to build instruments like Amperia that are affordable and simple, without compromising on performance.

Ruizhi Wang, CEO Abselion.

Abselion history

Our history

Abselion started in 2018, at that time under the name HexagonFab, in a small corner of a laboratory at the University of Cambridge. We set out with the humble goal to make protein research simpler. Scientists should be able to pursue their passion for discovery and innovation, rather than spend their valuable time with tedious, manual tasks. With RED we had access to the ideal technology to create this product. A product that is so compact that it could fit on every bench, and so affordable that it is accessible to everyone. Over the years we have designed, built and tested our first product Amperia and we’re proud to have introduced it to the world.​

Simple is better

Pressure to increase speed in the drug development process calls for more automation, more data and faster turnaround times. Solutions are required at the point of need, whether it is in research, process development or manufacturing. Data needs to be generated without the delay associated with sample transfer to central labs, decisions need to be made on the spot. Manual labour needs to be reduced for less errors and improved throughput. Amperia is our answer.

Performance alone is not enough. Simplicity and convenience is what make the difference. We built Amperia with the focus on effortless automation and simple workflow. Learn more about Amperia.

Abselion company

Interested in joining a dynamic and interdisciplinary team achieving amazing results?

Check out our open roles.
Amperia